Natural history of neuroendocrine enteropancreatic tumors.
about
Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversiesImaging of gastroenteropancreatic neuroendocrine tumorsMechanical stimulation activates Galphaq signaling pathways and 5-hydroxytryptamine release from human carcinoid BON cellsENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.Lymph nodes and survival in pancreatic neuroendocrine tumors.Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.The Treatment of Liver Metastases in Patients with Neuroendocrine Tumors in 2012Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.Duodenal Neuroendocrine Carcinoma Presenting with Disseminated Liver and Bone Metastases as the Primary Manifestation: Case Report and Literature Review.Nonfunctional Pancreatic Neuroendocrine Tumors: Advances in Diagnosis, Management, and Controversies.The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cells.Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors.Treatment of neuroendocrine tumor liver metastases.Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.Sandostatin LAR (long-acting octreotide acetate) for malignant carcinoid syndrome: a 3-year experience.Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.Rap1/B-Raf signaling is activated in neuroendocrine tumors of the digestive tract and Raf kinase inhibition constitutes a putative therapeutic target.
P2860
Q24647838-51E47818-2C5E-4391-BCDE-0CCB3714A18FQ28238305-9ACDD783-A6D2-4A4F-9590-1AC5F77134B6Q28360745-F0D2FE6B-E34D-4D34-9EA1-16415672DFE1Q34248466-F256B2DF-437B-4E05-B1A3-F3C107156349Q35843079-7011E2A9-4736-4841-AE72-1B179031D449Q36250472-FC983F76-E583-4997-955A-79CA34FDE62EQ36816158-B16D52D0-A8C3-431F-A108-DBB3241FC766Q36962070-DC3F59C1-F10B-4A56-BB60-5039714BB005Q37056120-423A05AA-EC8B-449F-8673-4F6A3D0264FBQ37832970-3A0B9846-73EE-45B8-BDCC-49C40E5C89FDQ37947138-BFB4818B-A951-4471-B13F-CC1F53A61B01Q37962416-EF2A2C56-82AE-47ED-9879-AE4D1E4183E6Q38309489-D71CB7D3-495E-427A-92B3-E61F533B3E15Q38319152-3DC2028C-F8D9-4E8B-AD1F-8407BA03408EQ40169305-C91242A6-E266-4461-98CA-51A724C31976Q40869761-1E9BCCF4-2BE4-4236-BACF-9F4460F6C9DFQ42287138-990E440E-9F3F-4E09-A004-EB46111C6E6AQ43921041-8FCCE812-E70A-4086-B4C9-E11078EF0BE7Q44299626-80B7D495-EF76-49D0-9BDF-B689AED44B8BQ47724538-351887B1-EF47-4D35-A0EE-8BE1BD722ABDQ50471116-30CA1285-466A-45BE-A2AA-EA0EDCA06F5A
P2860
Natural history of neuroendocrine enteropancreatic tumors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Natural history of neuroendocrine enteropancreatic tumors.
@ast
Natural history of neuroendocrine enteropancreatic tumors.
@en
Natural history of neuroendocrine enteropancreatic tumors.
@nl
type
label
Natural history of neuroendocrine enteropancreatic tumors.
@ast
Natural history of neuroendocrine enteropancreatic tumors.
@en
Natural history of neuroendocrine enteropancreatic tumors.
@nl
prefLabel
Natural history of neuroendocrine enteropancreatic tumors.
@ast
Natural history of neuroendocrine enteropancreatic tumors.
@en
Natural history of neuroendocrine enteropancreatic tumors.
@nl
P356
P1433
P1476
Natural history of neuroendocrine enteropancreatic tumors.
@en
P2093
P356
10.1159/000051856
P478
62 Suppl 1
P577
2000-01-01T00:00:00Z